Long-term survival outcomes with Nivolumab (Nivo) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response

被引：0
|
作者：
Wohlleber, M. [1 ]
Brahmer, J. [2 ]
Borghaei, H. [3 ]
Ramalingam, S. S. [4 ]
Horn, L. [5 ]
de Castro Carpeno, J. [6 ]
Pluzanski, A. [7 ]
Burgio, M. A. [8 ]
Garassino, M. [9 ]
Chow, L. Q. M. [10 ]
Gettinger, S. [11 ]
Crino, L. [7 ]
Planchard, D. [12 ]
Butts, C. [13 ]
Drilon, A. [14 ]
Wojcik-Tomaszewska, J. [15 ]
Otterson, G. [16 ]
Agrawal, S. [17 ]
Li, A. [17 ]
Penrod, J. R. [17 ]
Antonia, S. J. [18 ]
机构：
[1] Robert Bosch Ctr Tumorerkankungen RBCT, Dept Pneumol Oncol, Gerlingen, Germany
[2] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[3] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[6] Ctr Integral Oncol Clara Campal, Madrid, Spain
[7] Inst Marii Sklodowskiej Curie, Ctr Onkol, Klin Nowotworow Pluca & Klatki Piersiowej, Warsaw, Poland
[8] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCSS, Med Oncol Unit, Meldola, Italy
[9] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[10] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
[11] Yale Canc Ctr, New Haven, CT USA
[12] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[13] Cross Canc Inst, Dept Oncol, Div Med Oncol, Edmonton, AB, Canada
[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[15] Wojewodzkie Ctr Onkol, Gdansk, Poland
[16] Ohio State Univ, Columbus, OH 43210 USA
[17] Bristol Myers Squibb, Princeton, NJ USA
[18] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P406
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [31] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [32] Viagenpumatucel-L (HS-110) plus nivolumab in previously treated patients with advanced non-small cell lung cancer (NSCLC).
    Morgensztern, Daniel
    Bazhenova, Lyudmila
    Waqar, Saiama N.
    McDermott, Lori
    Hutchins, Jeff
    Harb, Wael
    Pennell, Nathan
    Cohen, Roger B.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 101 - 101
  • [33] EARLY CLOSURE OF A CLINICAL TRIAL OF DICHLOROACETATE IN PATIENTS WITH PREVIOUSLY TREATED, ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND BREAST CANCER
    Garon, Edward B.
    Hosmer, Wylie
    Britten, Carolyn
    Kabbinavar, Fairooz
    Michelakis, Evangelos D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1217 - S1218
  • [34] Outcomes of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) in A Regional Australian Population
    Kasherman, Lawrence
    Brungs, Daniel
    Bell, Graeme
    Glasgow, Amanda L.
    Tafreshi, Ali
    Clingan, Philip
    Aghmesheh, Morteza
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 145 - 146
  • [35] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [36] Clinical and Plasma Biomarkers for Disease Control with Nivolumab Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)
    Daher, Sameh
    Lawrence, Yaacov
    Dudnik, Elizabeth
    Hanovich, Ekaterina
    Urban, Damien
    Peled, Nir
    Navon, Rossie
    Leibowitz-Amit, Raya
    Hammerman, Ariel
    Battat, Erez
    Bar, Jair
    Onn, Amir
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1307 - S1307
  • [37] Long term survival of stage IIIB non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiation
    Mehmood, T.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [38] LONG-TERM SURVIVAL OF NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH SINGLE STATION N2 DISEASE TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Reymen, Bart
    Van Baardwijk, Angela
    Wanders, Rinus
    Borger, Jacques
    Houben, Ruud
    Dingemans, Anne-Marie C.
    Bootsma, Gerben
    Pitz, Cordula
    Lunde, Ragnar
    Lambin, Philippe
    De Ruysscher, Dirk
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1590 - S1591
  • [39] Second or Third Line Nivolumab Versus First Line Nivolumab in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)
    Martinez Moreno, E.
    Irigoyen Medina, A.
    Alvarez Cabellos, R.
    Martinez, K. A.
    Santiago, J.
    Rivilla, M.
    Cardenas, J. D.
    Esteban, C.
    Trujillo, B.
    Rosero, A.
    Fernandez, L.
    Ramos, I.
    Ramos, A.
    Chacon, J. I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S536 - S537
  • [40] Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib
    Nakatomi, K
    Soda, H
    Kitazaki, T
    Nakano, H
    Uchida, K
    Urabe, S
    Nakamura, Y
    Hayashi, T
    Tsukamoto, K
    Kohno, S
    [J]. LUNG CANCER, 2006, 52 (02) : 253 - 255
12345